Historical Valuation
GE Healthcare Technologies Inc (GEHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 17.22 is considered Undervalued compared with the five-year average of 18.18. The fair price of GE Healthcare Technologies Inc (GEHC) is between 89.15 to 103.76 according to relative valuation methord. Compared to the current price of 87.19 USD , GE Healthcare Technologies Inc is Undervalued By 2.2%.
Relative Value
Fair Zone
89.15-103.76
Current Price：87.19
2.2%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
GE Healthcare Technologies Inc (GEHC) has a current Price-to-Book (P/B) ratio of 3.78. Compared to its 3-year average P/B ratio of 4.19 , the current P/B ratio is approximately -9.95% higher. Relative to its 5-year average P/B ratio of 4.10, the current P/B ratio is about -8.01% higher. GE Healthcare Technologies Inc (GEHC) has a Forward Free Cash Flow (FCF) yield of approximately 3.71%. Compared to its 3-year average FCF yield of 4.63%, the current FCF yield is approximately -19.84% lower. Relative to its 5-year average FCF yield of 155960.72% , the current FCF yield is about -100.00% lower.
P/B
Median3y
4.19
Median5y
4.10
FCF Yield
Median3y
4.63
Median5y
155960.72
Competitors Valuation Multiple
AI Analysis for GEHC
The average P/S ratio for GEHC competitors is 3.99, providing a benchmark for relative valuation. GE Healthcare Technologies Inc Corp (GEHC.O) exhibits a P/S ratio of 1.78, which is -55.31% above the industry average. Given its robust revenue growth of 5.76%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for GEHC
1Y
3Y
5Y
Market capitalization of GEHC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of GEHC in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is GEHC currently overvalued or undervalued?
GE Healthcare Technologies Inc (GEHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 17.22 is considered Undervalued compared with the five-year average of 18.18. The fair price of GE Healthcare Technologies Inc (GEHC) is between 89.15 to 103.76 according to relative valuation methord. Compared to the current price of 87.19 USD , GE Healthcare Technologies Inc is Undervalued By 2.20% .
What is GE Healthcare Technologies Inc (GEHC) fair value?
GEHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of GE Healthcare Technologies Inc (GEHC) is between 89.15 to 103.76 according to relative valuation methord.
How does GEHC's valuation metrics compare to the industry average?
The average P/S ratio for GEHC's competitors is 3.99, providing a benchmark for relative valuation. GE Healthcare Technologies Inc Corp (GEHC) exhibits a P/S ratio of 1.78, which is -55.31% above the industry average. Given its robust revenue growth of 5.76%, this premium appears unsustainable.
What is the current P/B ratio for GE Healthcare Technologies Inc (GEHC) as of Jan 10 2026?
As of Jan 10 2026, GE Healthcare Technologies Inc (GEHC) has a P/B ratio of 3.78. This indicates that the market values GEHC at 3.78 times its book value.
What is the current FCF Yield for GE Healthcare Technologies Inc (GEHC) as of Jan 10 2026?
As of Jan 10 2026, GE Healthcare Technologies Inc (GEHC) has a FCF Yield of 3.71%. This means that for every dollar of GE Healthcare Technologies Inc’s market capitalization, the company generates 3.71 cents in free cash flow.
What is the current Forward P/E ratio for GE Healthcare Technologies Inc (GEHC) as of Jan 10 2026?
As of Jan 10 2026, GE Healthcare Technologies Inc (GEHC) has a Forward P/E ratio of 17.22. This means the market is willing to pay $17.22 for every dollar of GE Healthcare Technologies Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for GE Healthcare Technologies Inc (GEHC) as of Jan 10 2026?
As of Jan 10 2026, GE Healthcare Technologies Inc (GEHC) has a Forward P/S ratio of 1.78. This means the market is valuing GEHC at $1.78 for every dollar of expected revenue over the next 12 months.